Tortugas Neuroscience will develop drugs for brain disorders

Allison DeAngelis is the East Coast biotech and enterprise capital reporter at STAT, reporting the place scientific concepts and cash meet. She can also be co-host of the weekly biotech podcast, The Readout Loud. You’ll be able to attain Allison on Sign at AllisonDeAngelis.01.

A brand new startup has discovered that the Chinese language biotech trade is nice for greater than weight problems medicine and most cancers therapies. 

The corporate, Tortugas Neuroscience, launched Tuesday with plans to develop two schizophrenia and tinnitus medicine licensed from Chinese language drugmaker Jiangsu Hansoh Pharmaceutical Group. The startup will even take a look at two different medicines for focal epilepsy and encephalopathies that had been initially created by Japanese pharmaceutical firm Eisai Co. Ltd. 

Tortugas has $106 million from Treatment Ventures, The Column Group, and AN Ventures to start testing the medicine in mid-stage trials within the U.S.